Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Carcinoma, Hepatocellular 2Rare Malignant Neoplasm 1Myeloproliferative Disorders 1Melanoma 1Immunoglobulin Light-chain Amyloidosis 1Hereditary Sensory and Autonomic Neuropathies 1Hepatitis B 1Dysplastic Nevus Syndrome 1Complicated Adrenal Tumor Diseases 1Colorectal Adenocarcinoma 1Brain Neoplasms 1

Interventions

Blood Specimen Collection 6Flow Cytometry 4Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Immunoenzyme Techniques 3Amplified Fragment Length Polymorphism Analysis 3Watchful Waiting 2Therapeutics 2Microarray Analysis 2edoxaban 1apixaban 1X-Rays 1Valganciclovir 1Tinzaparin 1Surveys and Questionnaires 1Standard of Care 1Rivaroxaban 1Reverse Transcriptase Polymerase Chain Reaction 1Pharmaceutical Preparations 1Peripheral Blood Stem Cell Transplantation 1Observation 1Magnetic Resonance Imaging 1Influenza Vaccines 1In Situ Hybridization, Fluorescence 1Immunosuppression Therapy 1Immunologic Techniques 1Gene Expression Profiling 1Ganciclovir 1Foscarnet 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Myeloproliferative Disorders × Pharmaceutical Preparations × Clear all
NCT04994158 2025-07-30

MASCOT-R

Royal Free Hospital NHS Foundation Trust

Completed
238 enrolled
Myeloid

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡